» Articles » PMID: 30427560

Targeting Hippocampal Adult Neurogenesis Using Transcription Factors to Reduce Alzheimer's Disease-associated Memory Impairments

Overview
Journal Hippocampus
Publisher Wiley
Date 2018 Nov 15
PMID 30427560
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hippocampal adult neurogenesis results in the persisting formation of new neurons that contribute to hippocampal-dependent learning and memory. This has led to the hypothesis that memory impairments associated with neurodegenerative diseases such as Alzheimer's disease may involve abnormal neurogenesis. Supporting this idea, evidence for decreased adult neurogenesis has been reported in the brain of Alzheimer's disease patients and in several mouse models of the disease. Thus, the development of strategies designed to stimulate the production of new neurons in the diseased brain has raised growing interest. In this review, we discuss putative strategies and present recent studies showing that it is now possible to instruct hippocampal endogenous neural progenitors to adopt an exclusive neuronal fate. We further report how such strategies lead to the rescue of cognitive functions in mouse models of Alzheimer's disease. Altogether, these findings provide the proof-of-concept that neurogenesis can be stimulated in the adult brain in vivo, and consequently overcomes pathological memory deficits.

Citing Articles

Therapeutic advances in neural regeneration for Huntington's disease.

DEgidio F, Castelli V, Lombardozzi G, Ammannito F, Cimini A, dAngelo M Neural Regen Res. 2024; 19(9):1991-1997.

PMID: 38227527 PMC: 11040295. DOI: 10.4103/1673-5374.390969.


The Preventive Effects of Salubrinal against Pyrethroid-Induced Disruption of Adult Hippocampal Neurogenesis in Mice.

Toltin A, Belkadi A, Gamba L, Hossain M Int J Mol Sci. 2023; 24(21).

PMID: 37958604 PMC: 10648946. DOI: 10.3390/ijms242115614.


Discovery and validation of PURA as a transcription target of 20(S)-protopanaxadiol: Implications for the treatment of cognitive dysfunction.

Chen F, Zhang W, Xu S, Zhang H, Chen L, Chen C J Ginseng Res. 2023; 47(5):662-671.

PMID: 37720572 PMC: 10499581. DOI: 10.1016/j.jgr.2023.04.007.


BMP4-SMAD1/5/9-RUNX2 pathway activation inhibits neurogenesis and oligodendrogenesis in Alzheimer's patients' iPSCs in senescence-related conditions.

Nakatsu D, Kunishige R, Taguchi Y, Shinozaki-Narikawa N, Osaka K, Yokomizo K Stem Cell Reports. 2023; 18(3):688-705.

PMID: 36764297 PMC: 10031282. DOI: 10.1016/j.stemcr.2023.01.004.


Examination of Longitudinal Alterations in Alzheimer's Disease-Related Neurogenesis in an APP/PS1 Transgenic Mouse Model, and the Effects of P33, a Putative Neuroprotective Agent Thereon.

Szogi T, Borbely E, Schuster I, Bozso Z, Santha M, Toth M Int J Mol Sci. 2022; 23(18).

PMID: 36142277 PMC: 9499399. DOI: 10.3390/ijms231810364.